Cite

    Mostafa Dastani et al.. “Three months of combination therapy with nano‐curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double‐blinded, placebo‐controlled clinical trial.” BioFactors, vol. 49, 2023, pp. 108–118. http://access.bl.uk/ark:/81055/vdc_100179850945.0x00003a